Generic Mifepristone Maker Sues To Enjoin Any Status Change Without Due Process
GREENBELT, Md. — A generic drug manufacturer filed a civil complaint against the Food and Drug Administration and the Department of Justice to enjoin them from changing the approval of mifepristone...To view the full article, register now.
Already a subscriber? Click here to view full article